Zealand Pharma A/S, A Copenhagen-Based Biotechnology Company Focused On The Discovery And Development Of Innovative Peptide-Based Medicines, Announces The Acquisition Of Encycle Therapeutics, Inc., A Private Toronto-Based Biotech Company Exploiting A Unique Platform Technology That Enables The Rapid Synthesis Of Macrocyclic Peptides Exhibiting Enhanced Drug-Like Properties.The Acquisition Is Centered On A Pre-Clinical Lead Asset That Complements Zealand
